|
Zahlen für Q1/21
KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in 2021 and 2022
"The last patient from the MISSION Phase 1b completed treatment in February 2021, and final clinical data from this 25-week safety and tolerability study of up to 75 mg weekly of KZR-616 in 47 patients with SLE will be presented during the European Congress of Rheumatology (EULAR 2021) in June."
"The amended Phase 2 open-label portion of the MISSION trial in patients with active, proliferative lupus nephritis opened for enrollment in August 2020 and is actively recruiting."
Interim data are expected in late 2021, and topline data are expected in the first half of 2022.
www.kezarlifesciences.com/investors/...rter-financial-results
Zahlen für Q2/21
- KZR-616 MISSION Phase 1b study results support continued development for multiple immune mediated diseases
- Investigational new drug (IND) application filed for first-in-class protein secretion inhibitor, KZR-261
- Phase 2 open-label portion of the MISSION trial expects interim data to be reported in Q4 2021, and topline data are expected in the first half of 2022
www.kezarlifesciences.com/investors/...cond-quarter-financial
erster Patient in Phase 1 Studie (KZR-261) dosiert
www.kezarlifesciences.com/investors/...ed-in-phase-1-trial-of
positive Zwischenergebnisse der Phase 2 MISSION Studie KZR-616 (in LN)
www.kezarlifesciences.com/investors/...terim-results-from-the
Topline-Ergebnisse aus der PRESIDIO-Studie mit Zetomipzomib (KZR-616)
www.kezarlifesciences.com/investors/...from-presidio-trial-of
Zahlen für Q1/22
www.kezarlifesciences.com/investors/...quarter-2022-financial
Spekulative Wette auf die kommenden Studiendaten (LN).
positive Phase 2 MISSION-Studienergebnisse (LN)
ir.kezarlifesciences.com/news-releases/...ine-results-mission
Schöner Verdoppler in einem Monat.
Zahlen für Q4/22
ir.kezarlifesciences.com/news-releases/...r-and-year-end-2022
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 112 | KZR 18,33$ | Vassago | Vassago | 07.04.24 16:00 | |
4 | KZR 3,86$ (neues 52 WT) | Vassago | Vassago | 26.03.21 10:12 |